NEW YORK (GenomeWeb) – Fluidigm said today that it has signed an agreement with the University of Zurich to globally distribute the institution's histoCAT cytometry imaging software alongside its new Hyperion Imaging System.
Developed in the laboratory of Bernd Bodenmiller at the University of Zurich, histoCAT is designed to aid in the analysis of imaging mass cytometry data. For example, the tool can help examine cellular phenotypes and their interrelationships within a tissue sample, and includes novel algorithms to identify complex relationships between cells in healthy and disease states, Fluidigm said.
Additional details were described in a paper in Nature Methods this August.
"Through this new secondary analysis software, researchers can explore a wider range of new questions in conjunction with the Hyperion Imaging System workflow," Fluidigm President and CEO Chris Linthwaite said in a statement.
Under the agreement, Fluidigm will be selling the Zurich software alongside this new Hyperion system, also launched today. According to the company, Hyperion allows researchers to simultaneously image four to 37 protein markers with minimal background, and offers the ability to utilize up to 135 channels to detect additional parameters.